Bright Green Corporation implements an advanced system for Cannabinoid production, optimizing efficiency and quality. Through cost-effective indoor growing and a fully managed enclosed greenhouse ecosystem, the company achieves higher yields year-round. Rigorous security measures prevent cross-contamination, ensuring the integrity of each harvest. Additionally, efficient water use and pest control techniques contribute to high-quality crop production.
Our pharmaceutical researchers prize and emphasize product consistency for maintaining academic rigor. We produce our crop with tissue culture propagation—the growth of highly productive mature clones from tiny clippings in a manner to preserve consistency— to minimize disease and eliminate potential for genetic drift.
Bright Green’s plant breeding program begins with unique cultivars—selected by world-renowned experts—that are generated, cross-bred, and selected for crucial characteristics, including:
Our team exemplifies innovation in plant cultivation, enhancing greenhouse conditions sustainably to optimize growth and development.
We utilize automation technology and practices to streamline production, as well as improve efficiency and accuracy in compliance with strict federal regulations.